Harris R,Brown A,Lee J .2024 .Novel therapeutic approaches to inflammatory bowel disease: An update. J Gastroenterol Hepatol, 39(1) : 54-65.
.2024 .. Dermatol Res Pract, : 108432.
Lichtenstein GR,Feagan BG,Cohen RD .2024 .Management of skin manifestations in inflammatory bowel disease. Clin Gastroenterol Hepatol, 22(3) : 439-52.
Papp K,Bissonnette R .2024 .Pyoderma gangrenosum and inflammatory bowel disease: Pathogenesis and management. Am J Clin Dermatol, 25(2) : 135-44.
Zhao S,Lee T,Chang H. Psoriasis .2024 .and other cutaneous manifestations in inflammatory bowel disease: A comprehensive review. J Dermatol Treat, 35(4) : 482-90.
Johnson C,Wang S,Gupta A .2024 .Management strategies for complex dermatological manifestations of inflammatory bowel disease. J Clin Gastroenterol, 58(2) : 123-32.
Smith J,Williams R,Zhang X .2024 .The role of JAK inhibitors in treating inflammatory bowel disease and associated skin conditions. Ther Clin Risk Manag, 20 : 98-106.
Thompson D,Brooks L,O'Neil C. L . .The impact of biologic therapies on cutaneous manifestations in inflammatory bowel 1. , : .
.2024 .8. disease: A systematic review. Gastroenterology, 166(4) : 835-44.
Wong S,Wong R,Williams C. .2024 .The epidemiology of extraintestinal manifestations in inflammatory bowel disease: A review of recent studies. Inflamm Bowel Dis, 30(6) : 987-1002.
Greenberg M,Nielson M,Stewart D .2024 .Systemic and cutaneous inflammation in inflammatory bowel disease: Insights from recent research. J Inflamm Res, 17 : 89-100.
Alashkar Alhamwe B,Alhamdan F,Lindner N,Wang J,Stein M,Stockinger J .2023 .Skin manifestations in inflammatory bowel disease: Frequency, types, and management strategies. J Clin Gastroenterol, 57(4) : 331-6.
Nakano H,Ohara Y,Fujimoto M,Yamada T,Takahashi H,Sato Y .2023 .Cutaneous manifestations in Crohn's disease and ulcerative colitis: A comprehensive review of epidemiology and management. Dig Dis, 41(2) : 345-57.
Li P,Wang S,Chen Z,Huang J,Xu T,Li Y .2022 .Skin complications and disease activity in inflammatory bowel disease: Insights from a Chinese cohort study. BMC Gastroenterol, 22(1) : 112.
Marzano AV,Trevisan V,Lazzari R,Agostinelli C,Caputo R,Bonamonte D .2023 .Pathogenesis and management of erythema nodosum and pyoderma gangrenosum in inflammatory bowel disease. Curr Rheumatol Rep, 25(3) : 147-57.
Kumar V,Chawla SP,Makhija M,Bhalla S,Sharma R,Gupta M .2022 .Dermatological manifestations in patients with inflammatory bowel disease. J Assoc Physicians India, 70(1) : 11-5.
Mahendran R,Ferreira S,Taylor J,Nuno A,Barton S,Walker G .2022 .Incidence and management of paradoxical psoriasis induced by anti-TNF therapy in inflammatory bowel disease. Inflamm Bowel Dis, 28(5) : 769-75.
Bertani E,Grossi U,Tropini G,Prati M,Kattamis N,Buonomo O .2023 .Perianal skin tags in Crohn's disease: Surgical management and outcomes. Colorectal Dis, 25(6) : 915-22.
Sahu P,Jha V,Jain A,Sharma S,Singh R,Gupta A .2023 .Therapeutic implications of skin manifestations in Crohn's disease and ulcerative colitis. Expert Rev Clin Immunol, 19(1) : 55-64.
Inoue Y,Nomura K,Nakamura H,Takeda S,Suzuki T,Yamaguchi A .2022 .Clinical features and treatment outcomes of erythema nodosum in inflammatory bowel disease patients. Intern Med, 61(19) : 2943-50.
Li T,Wang H,Zhang H,Zhao W,Feng Y,Liu L .2023 .Systemic corticosteroids in the management of extraintestinal manifestations of inflammatory bowel disease: A systematic review. World J Clin Cases, 11(3) : 405-18.
Kochar B,Herfarth HH,Rubin DT,Szigethy E,Long MD,Osterman MT .2023 .Skin manifestations in IBD: Epidemiology, pathogenesis, and treatment. Inflamm Bowel Dis, 29(4) : 562-74.